La FDA approuve le comprimé Bixlenvo contre le VIH de Gilead pour les schémas ...
|
La FDA a approuvé le nouveau comprimé quotidien contre le VIH
de Gilead pour les patients suivant des traitements complexes. Bixlenvo
combine deux ... |
Français — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.